Increasing interest in real-world evidence (RWE) across all stakeholder groups has the industry buzzing about its current role in clinical trials and the potential impact of expanded use.

A new cross-industry effort hopes to research the benefits of RWE and promote acceptance of alternatives to traditional trials. While the buzz surrounding real world evidence (RWE) may make it ...

The second workshop focused on practical approaches for the collection of real-world data (RWD)—data generated outside of the traditional clinical trial setting—and the use of RWE. This publication ...

In a recent video interview with Applied Clinical Trials, Sujay Jadhav, CEO of Verana Health ... play in potential advancements around real-world evidence (RWE)/real-world data (RWD)? Jadhav: Looking ...

Hirsch also previously led SignalPath, a local clinical trial technology startup acquired by Verily in 2021. Acquiring Target RWE is an important step in Highlander's efforts to solve challenges ...

Shardul Nautiyal, Mumbai Thursday, January 30, 2025, 08:00 Hrs [IST] ...

High­lander Health, the clin­i­cal tri­al start­up co-found­ed by for­mer Ver­i­ly ex­ecs Amy Aber­nethy and Brad Hirsch, is ac­quir­ing da­ta com­pa­ny Tar­get RWE.